NCT06894329View on ClinicalTrials.gov

A Study for the PanCystPro Assay in the Management of Pancreatic Cystic Lesions

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

December 15, 2025

Primary Completion Date

June 15, 2026

Study Completion Date

March 16, 2027

Conditions
Pancreatic Cystic Lesions
Sponsors
All Listed Sponsors
lead

Amplified Sciences Inc

INDUSTRY

NCT06894329 - A Study for the PanCystPro Assay in the Management of Pancreatic Cystic Lesions | Biotech Hunter | Biotech Hunter